Trials Flashcards
ALBIOS
2014 n= 1800 Italian
Severe sepsis or septic shock
Does keeping albumin >30g/L improve mortality
No difference in 28 or 90 day mortality
Albumin group less time on vasoactive drugs and improved CVS parameters earlier in admission
No difference in SOFA score
Higher incidence on coag and liver dysfunction in albumin group
TRICS III
cardiac surgery patients
restrictive vs liberal transfusion practices
Restrictive was non inferior
- patients ok with Hb down to 75
LeoPARDS
2017
n = 500, multicentre
use of levo in sepsis
No improvement in mortality or SOFA scores
increased risk of arrythmias and longer MV
EAT ICU
2017
does early goal-directed nutrition (EGDN) during ICU stay compared to standard care nutrition delivery result in improved physical quality of life at 6 months
n = 200, single centre
used indirect calorimetry and urinary urea excretion to calculate needs, and 100% provided (with EN +PN as needed)
No difference in outcomes at 6/12
RECONNECT
OUtcome - In critically ill patients who pass a spontaneous breathing trial, reconnection to a ventilator for 1-hour compared with immediate extubation, significantly reduced the rate of re-intubation within 48 hours.
However - very underpowered
DETO2X - AMI - use of oxygen in suspected MI patients
n =>6000
Question - In patients with suspected myocardial infarction with no baseline hypoxia (sats >90%), does oxygen therapy or room air improve all-cause mortality at 1 year?
patients given 6l/min for 6-12hrs vs air
- supplemental oxygen made no difference to outcomes in normoxic patients with suspected AMI
- This result combined with other recent studies that have suggested potential harm from oxygen, plus the fact oxygen is not free, suggests that oxygen therapy in this population is no warranted
IVC collapsability in spont breathing critically ill and fluid responsiveness
Background - Assessing the collapsibility (or distensibility if the patient is mechanically ventilated) of the IVC during respiration using point of care ultrasound (POCUS) has been recommended by some clinicians as a means to assess fluid responsiveness, however this is controversial
Did find it identified patients who resonsded, BUT was a poorly deigned study with bad methodology
Use of HFNP in high risk patients following extubation
Background -
Hernandez has previously demonstrated that in low risk patients the risk of re-intubation can be decreased with the use of high-flow nasal oxygen post-exubation
Nava and Ferrer reported that in high risk patients, the use of post extubation non-invasive ventilation can reduce re-intubation rates and respiratory failure
Bottom line -
- This randomised controlled trial demonstrated that in patients that are high risk for re-intubation the use of high flow nasal oxygen was non-inferior to non-invasive ventilation
My practice -
In patients that are high risk for re-intubation I will use non-invasive ventilation, and if this not tolerated then change to high flow nasal oxygen
TRICOP
Restrictive vs liberal transfusion in cancer patients
No difference in 28 or 60 day mortality, but a difference in 90 days (BUT fragility index of 0)
ATHOS III
NEJM 2017
In patients with refractory vasodilatory shock does the addition of angiotensin II improve blood pressure compared with standard vasopressor therapy?
Bottom line -
Angiotensin II increases blood pressure in patients with vasodilatory shock
Numerically patients were less likely to have adverse events and die compared with the control group
This trial is likely to make angiotensin II available (the trial was conducted in consultation with the FDA)
DESIRE
Question - In ventilated patients with sepsis, does a sedation strategy with dexmedetomidine compared with no dexmedetomidine improve mortality and number of ventilator-free days?
The Bottom Line
In ventilated patients with sepsis or pancreatitis, this study fails to demonstrate a significant impact of dexmedetomidine on 28-day survival or ventilator-free days but was likely underpowered for mortality.
Levosimendan for Hemodynamic Support after Cardiac Surgery
Landoni. NEJM 2017
In patients undergoing cardiac surgery with peri-operative left ventricular dysfunction, it appears that a low-dose infusion of levosimendan is not beneficial
NB - didn’t use bolus, used much smaller doses for infusion
Levo CTS
Used prophylactically in CTS patients with LVEF <35%
Levosimendan does not have any clinical outcome benefit, when used as a prophylactic agent, in patients with poor left ventricular ejection fraction undergoing cardiac surgery on bypass
- used a low dose infusion and small bolus
Use of NIV upto 7 days after abdominal surgery in those who develop respiratory failure
Patient with hypoxia and acute resp distress up to 7 days after surgery
In this trial, 6 hours of low-level non-invasive ventilation in patients with acute hypoxic respiratory failure after major abdominal surgery reduced the need for re-intubation compared to standard oxygen therapy
no clinically relevant harm or intolerance was identified and therefore this paper will change my practice
Further studies comparing this strategy to high-flow nasal oxygen therapy are urgently needed
PRESERVE
NEJM 2017
high risk patients having interventional radiology
Does NAC or bicarb improve outcome
NO
terlipressin in cirrhosis and septic shock
In patients with cirrhosis and septic shock, this single centre non-blinded RCT demonstrated that terlipressin in comparison with noradrenaline improved haemodynamics and had a mortality benefit. Due to a number of methodological flaws and baseline differences I would want further evidence before this becomes standard practice.
Hybernatus
Hypothermia for Neuroprotection in Convulsive Status Epilepticus NEJM 2016
Intervention
Target core temperature of 32 to 34°C as rapidly as possible post randomisation
Target temperature maintained for 24 hours
Conclusions
In critically ill patients with convulsive status epilepticus receiving mechanical ventilation, the addition of therapeutic hypothermia to standard antiepileptic therapy showed no significant benefit with respect to good functional outcome
Dexmedetomidine for prevention of delirium in elderly (>65 yrs) patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial
Study drug started - low dose Dexmedetomidine
0.1mcg/kg/hr
If extubated: usually within 1 hour of admission to ITU post-operatively
If intubated: once sedation titrated to Richard-Agitation Sedation Score (RASS) -2 or higher
This study demonstrates an impressive reduction in post op delirium with low dose Dexmedetomidine infusion. Further studies needed to clarify if these results can be applied to a wider range of patients, and also to rule out possible safety concerns.
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients – RENAL trial NEJm 2009
Delivering higher intensity dialysis dosing is not without risk. Some of the potential disadvantages are; disturbance in electrolyte concentrations, increased costs and nursing workload, micronutrient depletion and subtherapeutic levels of antibiotics.
This is the best trial examining ‘dose’ of dialysis in critically ill patients and stands the test of time, even 8 years after publishing. I will continue my practice of dialysing critically ill patients with AKI at 25ml/kg/hr.
Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU) (OXYGEN-ICU)
Giradis. JAMA 2016
Question - In critically ill adults, does conservative oxygen therapy compared to liberal oxygen therapy reduce mortality?
94-98% vs >97%
Significantly lower mortality in conservative group
- need a larger RCT, avoid hyperoxia?
PATCH lancet 2016
In patients with acute intracerebral haemorrhage, associated with antiplatelet therapy, does platelet transfusion compared with standard care reduce death or dependence?
No - worse outcomes (small trial, but still…)
RESCUE ICP
Inclusion: patients with a TBI with an abnormal brain CT and raised intracranial pressure of >25mmHg for 1-12 hours, despite stage 1 and 2 measures; aged between 10 and 65 years
Intervention
Decompressive craniectomy
Continued stage 1 and 2 treatments plus decompressive craniectomy
Either large unilateral fronto-temporoparietal craniectomy (hemicraniectomy) for patients with unilateral hemispheric swelling or bifrontal craniectomy for patients with diffuse brain swelling
Improved mortality but worse functional outcome
EUROtherm3235
NEJM 2015
Clinical Question
In patients with traumatic brain injury (TBI), does hypothermia (32-35°C) and standard care compared to standard care alone reduce death and major disability at 6 months after injury?
In patients with ICP >20mmHg after TBI Cooling leads to worse mortality and functional outcome
VANISH NEJM 2016
Clinical Question
Does early vasopressin use reduce the risk of kidney failure in patients with septic shock compared with norepinephrine?
Study drug 1
Vasopressin (titrated up to 0.06 U/min) or Norepinephrine (titrated up to 12 μg/min)
Study drug 2
Hydrocortisone (50mg 6 hourly and then weaned) or Placebo
Bottom line -
- vasopressin does not reduce the number of renal replacement free days or mortality rate, and there was no clinical interaction with corticosteroids